MB Hema consult Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statetment report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Working capital requirement |
Debt-to-equity ratio |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2022 |
---|
24,220 |
- |
18,010 |
18,010 |
- |
0.74 |
0.00 |
100.00 |
74.36 |
18,010 |
12 |
0 |
18,022 |
2023 |
---|
9,310 |
- |
-361 |
-361 |
- |
1.90 |
0.04 |
100.00 |
-3.88 |
17,648 |
783 |
0 |
18,431 |
2024 |
---|
6,128 |
- |
-24 |
-24 |
- |
2.88 |
0.00 |
100.00 |
-0.39 |
17,624 |
12 |
0 |
17,636 |
Register and
explore Okredo data2024 |
---|
6,128 |
- |
-24 |
-24 |
- |
2.88 |
0.00 |
100.00 |
-0.39 |
17,624 |
12 |
0 |
17,636 |
Register and
explore Okredo data2024
Turnover (€)
6,128 €-34 % *
Sales per employee (€)
-Profit before tax (€)
-24 €93 % *
Net Profit (€)
-24 €93 % *
Profit per employee (€)
-Working capital requirement
2.88 51.58 % *
Debt-to-equity ratio
0.00 -100.00 % *
Total profitability (%)
100.00 %0.00 % *
Net profitability (%)
-0.39 %89.95 % *
Equity (€)
17,624 €0 % *
Amounts Payable And Liabilities (€)
12 €-98 % *
Non-current Assets (€)
0 €- *
CurrentAssets (€)
17,636 €-4 % *